Purpose: Protons traverse through tissue in nearly a straight line causing ionizations along their path with a density of ionization almost inversely proportional to their energy, continuing until their initial energy is exhausted at the end of their range. In comparison to the precisely described physical dose characteristics of proton beams, uncertainty remains in the biological and clinical effects of proton radiation. Preclinical studies have reported a measureable increase in RBE over the terminal few millimeters of the spread out Bragg peak (SOBP), which results in an extension of the bio-effective range of proton beams
1
. This finding of an increase in the relative biological effectiveness (RBE) at the distal end of proton therapy beams, however, has never been reported in a clinical study. This study compared the proton dose response of normal lung that received a terminating proton beam with the matched contralateral lung without a terminating beam.
Methods:
Thirty-four patients treated with proton therapy for esophageal cancer who received restaging [
18 F]-fluorodeoxyglucose positron emission tomography (FDG PET) were selected. Each received a proton field arrangement that included a lateral beam terminating in one lung. The pulmonary radiation inflammatory dose response was quantified for each lung separately as the slope of the FDG uptake versus dose using regression modeling. The dose-response was compared within subject between the entrance and end-range containing lungs using the related sample Wilcoxon signed rank test.
The proton dose distribution, radiation treatment planning (RTP) average CT, and restaging PET/CT images for each case were processed and evaluated using custom Matlab software (version 2011a, Mathworks Inc., Natick MA). The RTP CT and PET/CT CT were registered using an affine transformation following the approach described by Ourselin et al 2 and visually verified.
The standard uptake values (SUV) were calculated from the PET count rate using the following equation: 
The mean SUV within each lung, separately and combined, was obtained for each case. Using the registration between the RTP CT and the PET/CT CT, the mean SUV values in the lung tissue were obtained for each case over the dose ranges from 0 in 50 CGE in 2 CGE intervals. The median of SUV mean values and the range of the means for the 34 cases were determined. Histograms were formed of the FDG PET count rate versus radiation dose in 2-CGE intervals.SUV values within the lung were normalized with the values of lung irradiated by less then 2 CGE. A linear regression model was applied to the normalized [ 18 F]-FDG uptake to obtain the PMRR for each lung separately.
To find the optimum dose region for comparison between entry and end range lung, the relationship of the FDG uptake versus dose, average for the 34 cases, was compared for entry and end range lung. The point of maximum separation was used for analysis. To verify, related sample Wilcoxon sign rank test was used to compare the slopes for 1-6 CGE, 1-8 CGE, 1-10 CGE and 1-12 CGE.
Results:
Registered planning CT and PET CT were used to correlate SUV with dose for each patient (Figure 1 The spatial distribution of the regions that received between 1 and 10 Co-60 Gy Equivalents (CGE) corresponded to the proton beam lateral and distal edges. The point of maximum separation between the entry and end range lung on the graph of the relationship of the FDG uptake versus dose, average for the 34 cases, was 1-10 CGE. P values for the comparison between entry and end range lung for the proton dose -FDG response were p=0.033 for 1-6 CGE, p=0.011 for 1-8 CGE, p<0.000 for 1-10 CGE, and p=0.001 for 1-12 CGE. Conclusions: This study demonstrated an enhanced radiation dose response in lungs that received radiation from the proton beam end-range. This enhancement represents the first observable clinical manifestation of the increase in the RBE at the end range of proton beams. Spatial variation in the RBE invalidates the assumed isodose equals isoeffect. A variable RBE should be used in proton therapy planning. This technique may be useful in evaluating RBE models of other charged particles.
